Title: 1 AN ACT relating to buprenorphine products.
Official Title: 1 AN ACT relating to buprenorphine products.
Number of Sections: 1
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
UNOFFICIAL COPY 25 RS BR 951
2 Be it enacted by the General Assembly of the Commonwealth of Kentucky:
3 SECTION 1. A NEW SECTION OF KRS CHAPTER 311 IS CREATED TO
4 READ AS FOLLOWS:
5 (1) Notwithstanding any law to the contrary, a physician who is licensed in Kentucky
6 and meets the qualifications to prescribe, dispense, or administer Buprenorphine-
7 Mono-Product or Buprenorphine-Combined-with-Naloxone shall use
8 professional judgement to prescribe, dispense, or administer a specific dosage
9 regimen of Buprenorphine-Mono-Product or Buprenorphine-Combined-with-
10 Naloxone that best meets the treatment needs of a patient.
11 (2) The Kentucky Board of Medical Licensure shall not suspend, limit, or restrict a
12 license or take other disciplinary action against a physician who prescribes,
13 dispenses, or administers Buprenorphine-Mono-Product or Buprenorphine-
14 Combined-with-Naloxone to a patient in accordance with subsection (1) of this
15 section.
16 (3) The board shall promulgate administrative regulations in accordance with KRS
17 Chapter 13A to implement the requirements of this section.
18 SECTION 2. A NEW SECTION OF KRS CHAPTER 314 IS CREATED TO
19 READ AS FOLLOWS:
20 (1) Notwithstanding any law to the contrary, an advanced practice registered nurse
21 who is licensed in Kentucky and meets the qualifications to prescribe, dispense,
22 or administer Buprenorphine-Mono-Product or Buprenorphine-Combined-with-
23 Naloxone shall use professional judgement to prescribe, dispense, or administer a
24 specific dosage regimen of Buprenorphine-Mono-Product or Buprenorphine-
25 Combined-with-Naloxone that best meets the treatment needs of a patient.
26 (2) The board shall not suspend, limit, or restrict a license or take other disciplinary
27 action against an advanced practice registered nurse who prescribes, dispenses,
Page 1 of 2
XXXX 2/19/2025 9:52 AM Jacketed
UNOFFICIAL COPY 25 RS BR 951
1 or administers Buprenorphine-Mono-Product or Buprenorphine-Combined-with-
2 Naloxone to a patient in accordance with subsection (1) of this section.
3 (3) The board shall promulgate administrative regulations in accordance with KRS
4 Chapter 13A to implement the requirements of this section.
Page 2 of 2
XXXX 2/19/2025 9:52 AM Jacketed
[DELETED:   2  J A B S R ( N a M o B s u p j t p d o a a s d r o B o B N ( T l o t o d a a a p w p d o a B o B C s ( T C S R ( N w o N s d r o B o B C ( T a]
[DELETED:   2  J o N ( T C]


================================================================================

Raw Text:
UNOFFICIAL COPY 25 RS BR 951
1 AN ACT relating to buprenorphine products.
2 Be it enacted by the General Assembly of the Commonwealth of Kentucky:
3 SECTION 1. A NEW SECTION OF KRS CHAPTER 311 IS CREATED TO
4 READ AS FOLLOWS:
5 (1) Notwithstanding any law to the contrary, a physician who is licensed in Kentucky
6 and meets the qualifications to prescribe, dispense, or administer Buprenorphine-
7 Mono-Product or Buprenorphine-Combined-with-Naloxone shall use
8 professional judgement to prescribe, dispense, or administer a specific dosage
9 regimen of Buprenorphine-Mono-Product or Buprenorphine-Combined-with-
10 Naloxone that best meets the treatment needs of a patient.
11 (2) The Kentucky Board of Medical Licensure shall not suspend, limit, or restrict a
12 license or take other disciplinary action against a physician who prescribes,
13 dispenses, or administers Buprenorphine-Mono-Product or Buprenorphine-
14 Combined-with-Naloxone to a patient in accordance with subsection (1) of this
15 section.
16 (3) The board shall promulgate administrative regulations in accordance with KRS
17 Chapter 13A to implement the requirements of this section.
18 SECTION 2. A NEW SECTION OF KRS CHAPTER 314 IS CREATED TO
19 READ AS FOLLOWS:
20 (1) Notwithstanding any law to the contrary, an advanced practice registered nurse
21 who is licensed in Kentucky and meets the qualifications to prescribe, dispense,
22 or administer Buprenorphine-Mono-Product or Buprenorphine-Combined-with-
23 Naloxone shall use professional judgement to prescribe, dispense, or administer a
24 specific dosage regimen of Buprenorphine-Mono-Product or Buprenorphine-
25 Combined-with-Naloxone that best meets the treatment needs of a patient.
26 (2) The board shall not suspend, limit, or restrict a license or take other disciplinary
27 action against an advanced practice registered nurse who prescribes, dispenses,
Page 1 of 2
XXXX 2/19/2025 9:52 AM Jacketed

UNOFFICIAL COPY 25 RS BR 951
1 or administers Buprenorphine-Mono-Product or Buprenorphine-Combined-with-
2 Naloxone to a patient in accordance with subsection (1) of this section.
3 (3) The board shall promulgate administrative regulations in accordance with KRS
4 Chapter 13A to implement the requirements of this section.
Page 2 of 2
XXXX 2/19/2025 9:52 AM Jacketed

[DELETED:   2  J A B S R ( N a M o B s u p j t p d o a a s d r o B o B N ( T l o t o d a a a p w p d o a B o B C s ( T C S R ( N w o N s d r o B o B C ( T a]
[DELETED:   2  J o N ( T C]